{"id":"https://openalex.org/W4361962822","doi":"https://doi.org/10.1158/1078-0432.22488366","title":"Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy","display_name":"Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy","publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4361962822","doi":"https://doi.org/10.1158/1078-0432.22488366"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22488366","doi":"https://doi.org/10.1158/1078-0432.22488366","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488366","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22488366","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019473289","display_name":"Zev A. Wainberg","orcid":"https://orcid.org/0000-0002-7142-1246","observed_orcids":["https://orcid.org/0000-0002-7142-1246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zev A. Wainberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7142-1246","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043007782","display_name":"Arun S. Singh","orcid":"https://orcid.org/0000-0002-1633-7746","observed_orcids":["https://orcid.org/0000-0002-1633-7746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arun S. Singh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1633-7746","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062837404","display_name":"Gottfried E. Konecny","orcid":"https://orcid.org/0000-0001-6083-657X","observed_orcids":["https://orcid.org/0000-0001-6083-657X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gottfried E. Konecny","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6083-657X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062438676","display_name":"Kelly Elizabeth McCann","orcid":"https://orcid.org/0000-0001-8233-6242","observed_orcids":["https://orcid.org/0000-0001-8233-6242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly E. McCann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8233-6242","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001020016","display_name":"Joel Randolph Hecht","orcid":"https://orcid.org/0000-0003-2277-4157","observed_orcids":["https://orcid.org/0000-0003-2277-4157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Randolph Hecht","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2277-4157","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036134937","display_name":"Jonathan Wade Goldman","orcid":"https://orcid.org/0000-0002-4925-8243","observed_orcids":["https://orcid.org/0000-0002-4925-8243"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan Goldman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4925-8243","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039301683","display_name":"Bartosz Chmielowski","orcid":"https://orcid.org/0000-0002-2374-3320","observed_orcids":["https://orcid.org/0000-0002-2374-3320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bartosz Chmielowski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2374-3320","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073989429","display_name":"Richard S. Finn","orcid":"https://orcid.org/0000-0003-2494-2126","observed_orcids":["https://orcid.org/0000-0003-2494-2126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard S. Finn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2494-2126","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028010756","display_name":"Neil A. O\u2019Brien","orcid":"https://orcid.org/0000-0001-7408-1091","observed_orcids":["https://orcid.org/0000-0001-7408-1091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil O'Brien","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7408-1091","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045874340","display_name":"Erika von Euw","orcid":"https://orcid.org/0000-0002-3201-3311","observed_orcids":["https://orcid.org/0000-0002-3201-3311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika Von Euw","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3201-3311","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027665025","display_name":"Megan M. Price","orcid":"https://orcid.org/0000-0001-9572-5589","observed_orcids":["https://orcid.org/0000-0001-9572-5589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megan M. Price","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9572-5589","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050685252","display_name":"Diego Martinez","orcid":"https://orcid.org/0000-0002-5018-0017","observed_orcids":["https://orcid.org/0000-0002-5018-0017","https://orcid.org/0009-0003-6362-2325"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego Martinez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5018-0017","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044993968","display_name":"Lisa Yonemoto","orcid":"https://orcid.org/0000-0002-5545-7919","observed_orcids":["https://orcid.org/0000-0002-5545-7919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Yonemoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5545-7919","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103134941","display_name":"Meghan Brennan","orcid":"https://orcid.org/0000-0002-6679-1066","observed_orcids":["https://orcid.org/0000-0002-6679-1066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meghan Brennan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6679-1066","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1800-9076","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6330-498X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9399999976158142},{"id":"https://openalex.org/keywords/low-dose-chemotherapy","display_name":"low-dose chemotherapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.843999981880188},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8809999823570251}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6447827219963074},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5511849522590637},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5508548617362976},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5299305319786072},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5222266912460327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.467048317193985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35700514912605286}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22488366","doi":"https://doi.org/10.1158/1078-0432.22488366","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488366","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22488366.v1","doi":"https://doi.org/10.1158/1078-0432.22488366.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488366.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22488366","doi":"https://doi.org/10.1158/1078-0432.22488366","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488366","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296679693","https://openalex.org/W4361954200","https://openalex.org/W2979369544","https://openalex.org/W2511656656","https://openalex.org/W4376225652","https://openalex.org/W4223562117","https://openalex.org/W2501763128","https://openalex.org/W3129235907","https://openalex.org/W2991232411","https://openalex.org/W2560510769"],"abstract_inverted_index":{"Supplemental":[0],"Figure":[1],"S1.":[2],"Mean":[3],"pharmacokinetic":[4],"profiles":[5],"for":[6],"single":[7],"agent":[8],"talazoparib":[9],"(BMN673":[10],"in":[11],"phase":[12],"I":[13],"clinical":[14],"trial":[15],"PRP-001)":[16],"versus":[17],"combination":[18],"therapy.":[19]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}